This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Instytut Farmakologii Polskiej Akademii Nauk, Centre National De La Recherche Scientifique, Jagiellonian University. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kraków, PL (2017)
- Cracow, PL (2020)
Company Filing History:
2 out of 3 
1 out of 5,383 
1 out of 67 
Years Active: 2017-2020
Title: Grzegorz Satala: Innovator in Serotonin Receptor Research
Introduction
Grzegorz Satala is a notable inventor based in Kraków, Poland. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that interact with serotonin receptors. With a total of 2 patents, his work focuses on innovative solutions for treating various neurological and psychiatric disorders.
Latest Patents
One of his latest patents is titled "Imidazolyl-substituted indole derivatives binding 5-HT7 serotonin receptor and pharmaceutical compositions thereof." This invention introduces a new class of substituted indole derivatives that activate the 5-HT serotonin receptor. These compounds exhibit high affinity and selectivity for the receptor while possessing favorable physicochemical properties. They are the first described low-basicity 5-HT receptor agonists. The invention also discusses the use of these compounds in treating or preventing disorders related to the 5-HT receptor, particularly those affecting the central nervous system.
Another significant patent involves "Pyrroloquinoline derivatives as antagonists of 5-HT6 receptors." This invention details methods for preparing these compounds and novel intermediates useful for their synthesis. The compounds are intended for therapeutic applications in various conditions, including schizophrenia, anxiety, depression, and cognitive disorders. The general formula for these compounds is provided in the patent description.
Career Highlights
Grzegorz Satala has worked with esteemed institutions such as the Institute of Pharmacology of the Polish Academy of Sciences and Jagiellonian University. His research has contributed to advancements in understanding serotonin receptor interactions and their implications for mental health treatments.
Collaborations
Throughout his career, Grzegorz has collaborated with notable colleagues, including Andrzej J. Bojarski and Adam Hogendorf. These partnerships have fostered a collaborative environment for innovative research and development in pharmacology.
Conclusion
Grzegorz Satala's contributions to serotonin receptor research and his innovative patents highlight his role as a significant figure in pharmacological advancements. His work continues to pave the way for new therapeutic options in treating complex neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile